Human Serum

Human Serum Comprehensive Study by Type (Pooled Human Serum, Single Donor Human Serum), Application (Scientific Research, Industrial Production) Players and Region - Global Market Outlook to 2030

Human Serum Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 9.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Human Serum
Human serum is a component of blood which is obtained from the blood plasma of individuals or donors. It is a complex fluid containing various range of proteins. However, it does not contain fibrinogen and other clotting factors. Eliminating these components the serum contains 60 -80 mg of protein. Human serum is differentiated on the basis of age, gender, and disease states. It is used in diagnostic tests and blood typing. These factors and applications is increasing the demand of human serum.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR9.2%


The key manufacturers are targeting the innovations of the products with better quality, and better technical characteristics, and also assist in providing and humanizing the after-sale service to the consumers. The key players are probable to keep a stronghold on the market over the anticipated period. The key players are accepting strategic decisions and are thinking about mergers and acquisitions to maintain their presence in the market Analyst at AMA Research estimates that United States Players will contribute the maximum growth to Global Human Serum market throughout the forecasted period. Established and emerging Players should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Biological Industries (Israel), Sigma-Aldrich (United States), Thermo Fisher (United States), Millipore Sigma (United States), Valley biomedical (Unite States), Innovative research (United States), BioIVT (United States) and Rocky Mountain Biologicals (United States) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Human Serum market by Type (Pooled Human Serum and Single Donor Human Serum), Application (Scientific Research and Industrial Production) and Region.



On the basis of geography, the market of Human Serum has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).

Influencing Trend:
Increasing Research Activities

Market Growth Drivers:
Rising Prevalence of Chronic Diseases

Challenges:
Presence of Stiff Regulations is Hampering the Market Growth

Opportunities:
Increasing Spending on Medicines and Growing Penetration of Products Derived from Plasma

Market Leaders and their expansionary development strategies
In 2019, Thermo fisher has acquired GSK manufacturing site in Ireland. This acquisition will provide all the required regulatory approvals.
In February 2024, Gemini Bioproducts, LLC (GeminiBio), announced the launch of a new human AB serum product for cell therapy and regenerative medicine.


Key Target Audience
Manufacturers, Distributors and Traders, Research Organisations, Government Agencies and Organisations

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Type
  • Pooled Human Serum
  • Single Donor Human Serum
By Application
  • Scientific Research
  • Industrial Production
By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Prevalence of Chronic Diseases
    • 3.3. Market Challenges
      • 3.3.1. Presence of Stiff Regulations is Hampering the Market Growth
    • 3.4. Market Trends
      • 3.4.1. Increasing Research Activities
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Human Serum, by Type, Application and Region (value) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Human Serum (Value)
      • 5.2.1. Global Human Serum by: Type (Value)
        • 5.2.1.1. Pooled Human Serum
        • 5.2.1.2. Single Donor Human Serum
      • 5.2.2. Global Human Serum by: Application (Value)
        • 5.2.2.1. Scientific Research
        • 5.2.2.2. Industrial Production
      • 5.2.3. Global Human Serum Region
        • 5.2.3.1. South America
          • 5.2.3.1.1. Brazil
          • 5.2.3.1.2. Argentina
          • 5.2.3.1.3. Rest of South America
        • 5.2.3.2. Asia Pacific
          • 5.2.3.2.1. China
          • 5.2.3.2.2. Japan
          • 5.2.3.2.3. India
          • 5.2.3.2.4. South Korea
          • 5.2.3.2.5. Taiwan
          • 5.2.3.2.6. Australia
          • 5.2.3.2.7. Rest of Asia-Pacific
        • 5.2.3.3. Europe
          • 5.2.3.3.1. Germany
          • 5.2.3.3.2. France
          • 5.2.3.3.3. Italy
          • 5.2.3.3.4. United Kingdom
          • 5.2.3.3.5. Netherlands
          • 5.2.3.3.6. Rest of Europe
        • 5.2.3.4. MEA
          • 5.2.3.4.1. Middle East
          • 5.2.3.4.2. Africa
        • 5.2.3.5. North America
          • 5.2.3.5.1. United States
          • 5.2.3.5.2. Canada
          • 5.2.3.5.3. Mexico
  • 6. Human Serum: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Biological Industries (Israel)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Sigma-Aldrich (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Thermo Fisher (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Millipore Sigma (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Valley biomedical (Unite States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Innovative research (United States)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. BioIVT (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Rocky Mountain Biologicals (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Human Serum Sale, by Type, Application and Region (value) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Human Serum (Value)
      • 7.2.1. Global Human Serum by: Type (Value)
        • 7.2.1.1. Pooled Human Serum
        • 7.2.1.2. Single Donor Human Serum
      • 7.2.2. Global Human Serum by: Application (Value)
        • 7.2.2.1. Scientific Research
        • 7.2.2.2. Industrial Production
      • 7.2.3. Global Human Serum Region
        • 7.2.3.1. South America
          • 7.2.3.1.1. Brazil
          • 7.2.3.1.2. Argentina
          • 7.2.3.1.3. Rest of South America
        • 7.2.3.2. Asia Pacific
          • 7.2.3.2.1. China
          • 7.2.3.2.2. Japan
          • 7.2.3.2.3. India
          • 7.2.3.2.4. South Korea
          • 7.2.3.2.5. Taiwan
          • 7.2.3.2.6. Australia
          • 7.2.3.2.7. Rest of Asia-Pacific
        • 7.2.3.3. Europe
          • 7.2.3.3.1. Germany
          • 7.2.3.3.2. France
          • 7.2.3.3.3. Italy
          • 7.2.3.3.4. United Kingdom
          • 7.2.3.3.5. Netherlands
          • 7.2.3.3.6. Rest of Europe
        • 7.2.3.4. MEA
          • 7.2.3.4.1. Middle East
          • 7.2.3.4.2. Africa
        • 7.2.3.5. North America
          • 7.2.3.5.1. United States
          • 7.2.3.5.2. Canada
          • 7.2.3.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Human Serum: by Type(USD Million)
  • Table 2. Human Serum Pooled Human Serum , by Region USD Million (2018-2023)
  • Table 3. Human Serum Single Donor Human Serum , by Region USD Million (2018-2023)
  • Table 4. Human Serum: by Application(USD Million)
  • Table 5. Human Serum Scientific Research , by Region USD Million (2018-2023)
  • Table 6. Human Serum Industrial Production , by Region USD Million (2018-2023)
  • Table 7. South America Human Serum, by Country USD Million (2018-2023)
  • Table 8. South America Human Serum, by Type USD Million (2018-2023)
  • Table 9. South America Human Serum, by Application USD Million (2018-2023)
  • Table 10. Brazil Human Serum, by Type USD Million (2018-2023)
  • Table 11. Brazil Human Serum, by Application USD Million (2018-2023)
  • Table 12. Argentina Human Serum, by Type USD Million (2018-2023)
  • Table 13. Argentina Human Serum, by Application USD Million (2018-2023)
  • Table 14. Rest of South America Human Serum, by Type USD Million (2018-2023)
  • Table 15. Rest of South America Human Serum, by Application USD Million (2018-2023)
  • Table 16. Asia Pacific Human Serum, by Country USD Million (2018-2023)
  • Table 17. Asia Pacific Human Serum, by Type USD Million (2018-2023)
  • Table 18. Asia Pacific Human Serum, by Application USD Million (2018-2023)
  • Table 19. China Human Serum, by Type USD Million (2018-2023)
  • Table 20. China Human Serum, by Application USD Million (2018-2023)
  • Table 21. Japan Human Serum, by Type USD Million (2018-2023)
  • Table 22. Japan Human Serum, by Application USD Million (2018-2023)
  • Table 23. India Human Serum, by Type USD Million (2018-2023)
  • Table 24. India Human Serum, by Application USD Million (2018-2023)
  • Table 25. South Korea Human Serum, by Type USD Million (2018-2023)
  • Table 26. South Korea Human Serum, by Application USD Million (2018-2023)
  • Table 27. Taiwan Human Serum, by Type USD Million (2018-2023)
  • Table 28. Taiwan Human Serum, by Application USD Million (2018-2023)
  • Table 29. Australia Human Serum, by Type USD Million (2018-2023)
  • Table 30. Australia Human Serum, by Application USD Million (2018-2023)
  • Table 31. Rest of Asia-Pacific Human Serum, by Type USD Million (2018-2023)
  • Table 32. Rest of Asia-Pacific Human Serum, by Application USD Million (2018-2023)
  • Table 33. Europe Human Serum, by Country USD Million (2018-2023)
  • Table 34. Europe Human Serum, by Type USD Million (2018-2023)
  • Table 35. Europe Human Serum, by Application USD Million (2018-2023)
  • Table 36. Germany Human Serum, by Type USD Million (2018-2023)
  • Table 37. Germany Human Serum, by Application USD Million (2018-2023)
  • Table 38. France Human Serum, by Type USD Million (2018-2023)
  • Table 39. France Human Serum, by Application USD Million (2018-2023)
  • Table 40. Italy Human Serum, by Type USD Million (2018-2023)
  • Table 41. Italy Human Serum, by Application USD Million (2018-2023)
  • Table 42. United Kingdom Human Serum, by Type USD Million (2018-2023)
  • Table 43. United Kingdom Human Serum, by Application USD Million (2018-2023)
  • Table 44. Netherlands Human Serum, by Type USD Million (2018-2023)
  • Table 45. Netherlands Human Serum, by Application USD Million (2018-2023)
  • Table 46. Rest of Europe Human Serum, by Type USD Million (2018-2023)
  • Table 47. Rest of Europe Human Serum, by Application USD Million (2018-2023)
  • Table 48. MEA Human Serum, by Country USD Million (2018-2023)
  • Table 49. MEA Human Serum, by Type USD Million (2018-2023)
  • Table 50. MEA Human Serum, by Application USD Million (2018-2023)
  • Table 51. Middle East Human Serum, by Type USD Million (2018-2023)
  • Table 52. Middle East Human Serum, by Application USD Million (2018-2023)
  • Table 53. Africa Human Serum, by Type USD Million (2018-2023)
  • Table 54. Africa Human Serum, by Application USD Million (2018-2023)
  • Table 55. North America Human Serum, by Country USD Million (2018-2023)
  • Table 56. North America Human Serum, by Type USD Million (2018-2023)
  • Table 57. North America Human Serum, by Application USD Million (2018-2023)
  • Table 58. United States Human Serum, by Type USD Million (2018-2023)
  • Table 59. United States Human Serum, by Application USD Million (2018-2023)
  • Table 60. Canada Human Serum, by Type USD Million (2018-2023)
  • Table 61. Canada Human Serum, by Application USD Million (2018-2023)
  • Table 62. Mexico Human Serum, by Type USD Million (2018-2023)
  • Table 63. Mexico Human Serum, by Application USD Million (2018-2023)
  • Table 64. Company Basic Information, Sales Area and Its Competitors
  • Table 65. Company Basic Information, Sales Area and Its Competitors
  • Table 66. Company Basic Information, Sales Area and Its Competitors
  • Table 67. Company Basic Information, Sales Area and Its Competitors
  • Table 68. Company Basic Information, Sales Area and Its Competitors
  • Table 69. Company Basic Information, Sales Area and Its Competitors
  • Table 70. Company Basic Information, Sales Area and Its Competitors
  • Table 71. Company Basic Information, Sales Area and Its Competitors
  • Table 72. Human Serum: by Type(USD Million)
  • Table 73. Human Serum Pooled Human Serum , by Region USD Million (2025-2030)
  • Table 74. Human Serum Single Donor Human Serum , by Region USD Million (2025-2030)
  • Table 75. Human Serum: by Application(USD Million)
  • Table 76. Human Serum Scientific Research , by Region USD Million (2025-2030)
  • Table 77. Human Serum Industrial Production , by Region USD Million (2025-2030)
  • Table 78. South America Human Serum, by Country USD Million (2025-2030)
  • Table 79. South America Human Serum, by Type USD Million (2025-2030)
  • Table 80. South America Human Serum, by Application USD Million (2025-2030)
  • Table 81. Brazil Human Serum, by Type USD Million (2025-2030)
  • Table 82. Brazil Human Serum, by Application USD Million (2025-2030)
  • Table 83. Argentina Human Serum, by Type USD Million (2025-2030)
  • Table 84. Argentina Human Serum, by Application USD Million (2025-2030)
  • Table 85. Rest of South America Human Serum, by Type USD Million (2025-2030)
  • Table 86. Rest of South America Human Serum, by Application USD Million (2025-2030)
  • Table 87. Asia Pacific Human Serum, by Country USD Million (2025-2030)
  • Table 88. Asia Pacific Human Serum, by Type USD Million (2025-2030)
  • Table 89. Asia Pacific Human Serum, by Application USD Million (2025-2030)
  • Table 90. China Human Serum, by Type USD Million (2025-2030)
  • Table 91. China Human Serum, by Application USD Million (2025-2030)
  • Table 92. Japan Human Serum, by Type USD Million (2025-2030)
  • Table 93. Japan Human Serum, by Application USD Million (2025-2030)
  • Table 94. India Human Serum, by Type USD Million (2025-2030)
  • Table 95. India Human Serum, by Application USD Million (2025-2030)
  • Table 96. South Korea Human Serum, by Type USD Million (2025-2030)
  • Table 97. South Korea Human Serum, by Application USD Million (2025-2030)
  • Table 98. Taiwan Human Serum, by Type USD Million (2025-2030)
  • Table 99. Taiwan Human Serum, by Application USD Million (2025-2030)
  • Table 100. Australia Human Serum, by Type USD Million (2025-2030)
  • Table 101. Australia Human Serum, by Application USD Million (2025-2030)
  • Table 102. Rest of Asia-Pacific Human Serum, by Type USD Million (2025-2030)
  • Table 103. Rest of Asia-Pacific Human Serum, by Application USD Million (2025-2030)
  • Table 104. Europe Human Serum, by Country USD Million (2025-2030)
  • Table 105. Europe Human Serum, by Type USD Million (2025-2030)
  • Table 106. Europe Human Serum, by Application USD Million (2025-2030)
  • Table 107. Germany Human Serum, by Type USD Million (2025-2030)
  • Table 108. Germany Human Serum, by Application USD Million (2025-2030)
  • Table 109. France Human Serum, by Type USD Million (2025-2030)
  • Table 110. France Human Serum, by Application USD Million (2025-2030)
  • Table 111. Italy Human Serum, by Type USD Million (2025-2030)
  • Table 112. Italy Human Serum, by Application USD Million (2025-2030)
  • Table 113. United Kingdom Human Serum, by Type USD Million (2025-2030)
  • Table 114. United Kingdom Human Serum, by Application USD Million (2025-2030)
  • Table 115. Netherlands Human Serum, by Type USD Million (2025-2030)
  • Table 116. Netherlands Human Serum, by Application USD Million (2025-2030)
  • Table 117. Rest of Europe Human Serum, by Type USD Million (2025-2030)
  • Table 118. Rest of Europe Human Serum, by Application USD Million (2025-2030)
  • Table 119. MEA Human Serum, by Country USD Million (2025-2030)
  • Table 120. MEA Human Serum, by Type USD Million (2025-2030)
  • Table 121. MEA Human Serum, by Application USD Million (2025-2030)
  • Table 122. Middle East Human Serum, by Type USD Million (2025-2030)
  • Table 123. Middle East Human Serum, by Application USD Million (2025-2030)
  • Table 124. Africa Human Serum, by Type USD Million (2025-2030)
  • Table 125. Africa Human Serum, by Application USD Million (2025-2030)
  • Table 126. North America Human Serum, by Country USD Million (2025-2030)
  • Table 127. North America Human Serum, by Type USD Million (2025-2030)
  • Table 128. North America Human Serum, by Application USD Million (2025-2030)
  • Table 129. United States Human Serum, by Type USD Million (2025-2030)
  • Table 130. United States Human Serum, by Application USD Million (2025-2030)
  • Table 131. Canada Human Serum, by Type USD Million (2025-2030)
  • Table 132. Canada Human Serum, by Application USD Million (2025-2030)
  • Table 133. Mexico Human Serum, by Type USD Million (2025-2030)
  • Table 134. Mexico Human Serum, by Application USD Million (2025-2030)
  • Table 135. Research Programs/Design for This Report
  • Table 136. Key Data Information from Secondary Sources
  • Table 137. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Human Serum: by Type USD Million (2018-2023)
  • Figure 5. Global Human Serum: by Application USD Million (2018-2023)
  • Figure 6. South America Human Serum Share (%), by Country
  • Figure 7. Asia Pacific Human Serum Share (%), by Country
  • Figure 8. Europe Human Serum Share (%), by Country
  • Figure 9. MEA Human Serum Share (%), by Country
  • Figure 10. North America Human Serum Share (%), by Country
  • Figure 11. Global Human Serum share by Players 2023 (%)
  • Figure 12. Global Human Serum share by Players (Top 3) 2023(%)
  • Figure 13. Global Human Serum share by Players (Top 5) 2023(%)
  • Figure 14. BCG Matrix for key Companies
  • Figure 15. Biological Industries (Israel) Revenue, Net Income and Gross profit
  • Figure 16. Biological Industries (Israel) Revenue: by Geography 2023
  • Figure 17. Sigma-Aldrich (United States) Revenue, Net Income and Gross profit
  • Figure 18. Sigma-Aldrich (United States) Revenue: by Geography 2023
  • Figure 19. Thermo Fisher (United States) Revenue, Net Income and Gross profit
  • Figure 20. Thermo Fisher (United States) Revenue: by Geography 2023
  • Figure 21. Millipore Sigma (United States) Revenue, Net Income and Gross profit
  • Figure 22. Millipore Sigma (United States) Revenue: by Geography 2023
  • Figure 23. Valley biomedical (Unite States) Revenue, Net Income and Gross profit
  • Figure 24. Valley biomedical (Unite States) Revenue: by Geography 2023
  • Figure 25. Innovative research (United States) Revenue, Net Income and Gross profit
  • Figure 26. Innovative research (United States) Revenue: by Geography 2023
  • Figure 27. BioIVT (United States) Revenue, Net Income and Gross profit
  • Figure 28. BioIVT (United States) Revenue: by Geography 2023
  • Figure 29. Rocky Mountain Biologicals (United States) Revenue, Net Income and Gross profit
  • Figure 30. Rocky Mountain Biologicals (United States) Revenue: by Geography 2023
  • Figure 31. Global Human Serum: by Type USD Million (2025-2030)
  • Figure 32. Global Human Serum: by Application USD Million (2025-2030)
  • Figure 33. South America Human Serum Share (%), by Country
  • Figure 34. Asia Pacific Human Serum Share (%), by Country
  • Figure 35. Europe Human Serum Share (%), by Country
  • Figure 36. MEA Human Serum Share (%), by Country
  • Figure 37. North America Human Serum Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Biological Industries (Israel)
  • Sigma-Aldrich (United States)
  • Thermo Fisher (United States)
  • Millipore Sigma (United States)
  • Valley biomedical (Unite States)
  • Innovative research (United States)
  • BioIVT (United States)
  • Rocky Mountain Biologicals (United States)
Select User Access Type

Key Highlights of Report


Jun 2024 217 Pages 56 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Human Serum Quantitative research analysis
Human Serum Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Biological Industries (Israel), Sigma-Aldrich (United States), Thermo Fisher (United States), Millipore Sigma (United States), Valley biomedical (Unite States), Innovative research (United States), BioIVT (United States) and Rocky Mountain Biologicals (United States) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Increasing Research Activities" is seen as one of major influencing trends for Human Serum Market during projected period 2023-2030.
The Human Serum market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Human Serum Report?

Have a Query? Click Here

Other Related Reports

Gel Documentation Systems Comprehensive Study by Type (Instruments, Software, Accessories), Application (Nucleic Acid Quantification, Protein Quantification, Others), Light Source (LED, UV, Laser), D...
$ 3800
Bispecific Antibody Comprehensive Study by Application (Diagnosis of Bacterial Infections, Diagnosis of Viral Infections, BsMAb for Cancer Diagnostic, BsAbs Blocking Signaling Pathways, BsAbs Targeti...
$ 3750
Soybean Trypsin Inhibitor Comprehensive Study by Type (Purity >90%, Purity >95%, Other), Application (Scientific Research, Industrial Production), Form (Powder, Liquid), End User (Pharmaceutical Comp...
$ 3350
Bioprocess Technology Comprehensive Study by Type (Cell Expansion, Cell Culture, Cell Line Development, Flow Cytometry, Virus Infiltration), Application (Specialty Products, Biopharmaceuticals, Envir...
$ 3650
Waste-to-Energy Technologies Comprehensive Study by Type (Thermal, Thermo-Chemical, Mechanical-Thermal, Biochemical), Application (Heat, Fuels, Electricity), Waste Type (Municipal Solid Waste (MSW), ...
$ 3800
Antibiotic Residue Test Kits Comprehensive Study by Sales Channel (Online, Offline), End-Use (Food and Beverage Industry, Veterinary, Independent Laboratory, Others), Test Type (Beta-lactams, Macroli...
$ 3450